Age, Metabolic Control and Type of Insulin Regime Influences Health-related Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus
Overview
Affiliations
Unlabelled: The effects of illness and treatment of diabetes mellitus extend beyond medical outcomes. We therefore evaluated health-related quality of life (HRQOL) in children (aged 8-12 years) and adolescents (aged 13-16 years) with type 1 diabetes to compare their results with healthy peers and to identify HRQOL determinants. A total of 68 children and adolescents from a tertiary care clinic which specialises in the management of diabetes, completed the generic KINDL-R questionnaire. This instrument for children and adolescents has six dimensions and an additional module assessing condition-related HRQOL. Overall, the HRQOL was not different between patients with type 1 diabetes and healthy controls. In some areas, children and adolescents with diabetes reported a better HRQOL compared to healthy peers: adolescents reported better psychological well-being (P < 0.05) and children higher levels of well-being in the school domain (P < 0.05). In general, children reported a better HRQOL (P < 0.05) than adolescents with type 1 diabetes confirming age-related differences in HRQOL in the general population. Lower HbA1c (<8%) and intensified insulin therapy (>3 injections/day) were associated with a better HRQOL in different domains (P < 0.05). The subscale "chronic illness" showed a better HRQOL (P < 0.001) in children and adolescents with diabetes compared to age-matched controls with other chronic conditions.
Conclusion: Children and adolescents from a paediatric department specialising in diabetes management report good health-related quality of life. Younger age, good metabolic control and intensified insulin therapy are associated with a better health-related quality of life. Dimensions of health-related quality of life appear to play different roles at different ages, emphasising the importance of the multidimensional health-related quality of life concept and the value of age-appropriate self-reports.
Franceschi R, Pertile R, Marigliano M, Mozzillo E, Maffeis C, Candia F Acta Diabetol. 2024; 61(8):987-995.
PMID: 38615127 PMC: 11329396. DOI: 10.1007/s00592-024-02281-6.
Shigeyasu Y, Okada A, Fujii C, Tanaka C, Sugihara A, Horiuchi M Biopsychosoc Med. 2023; 17(1):23.
PMID: 37308984 PMC: 10258988. DOI: 10.1186/s13030-023-00278-1.
Bratke H, Biringer E, Margeirsdottir H, Njolstad P, Skrivarhaug T J Diabetes Res. 2022; 2022:8401328.
PMID: 36387938 PMC: 9649325. DOI: 10.1155/2022/8401328.
Azulay R, Lago D, Santos G, da Gloria Tavares M, Rodrigues V, Magalhaes M Sci Rep. 2022; 12(1):11060.
PMID: 35773385 PMC: 9246993. DOI: 10.1038/s41598-022-15138-1.
Coolen M, Broadley M, Hendrieckx C, Chatwin H, Clowes M, Heller S PLoS One. 2021; 16(12):e0260896.
PMID: 34855927 PMC: 8638919. DOI: 10.1371/journal.pone.0260896.